EQS-Adhoc: Relief Therapeutics Holding SA: Relief Therapeuti

Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing 26-Apr-2022 / 07:00 CET/CEST Release of an ad hoc

Related Keywords

Geneva , Genè , Switzerland , Secheron , Switzerland General , Swiss , Zinuara Pharma , Anthony Kim , Michael Miller , Jack Weinstein , Advita Lifescience Gmb , Relief Therapeutics Holding Sa Key , Linkedin , Rx Communications Group , Cubist Pharmaceuticals , Intercept Pharmaceuticals , Brown University , News Service , Division Of Health Sciences , Pharma Research , Swiss Exchange , Exchange Commission , Harvard Business School , Master Of Business Administration , Us Marketing At Intercept Pharmaceuticals Inc , Us Marketing Department , Relief Therapeutics Holding , Neurorx Inc , Therapeutics Appoints Drew Cronin Fine , Executive Director , Rare Diseases , Digital Innovation , New Product Launches , Drew Cronin Fine , Senior Vice President , Drug User Fee Act , Urea Cycle Disorders , Acer Therapeutics , Relief Therapeutics , Associate Director , Chief Operating Officer , Business Administration , Health Sciences , Vasoactive Intestinal Peptide , License Agreement , Maple Syrup Urine , Advita Lifescience Gmbh , Financial Officer , Adhoc , Relief , Herapeutics , Molding , Ppoints , Crew , Cronin , Line , Executive , Director , Head , Marketing ,